文献速递肝病

IgA富集表型可预测MASLD肝脏相关事件

IgA-enriched phenotype predicts liver-related events in MASLD.
PubMed 文献 · J Hepatol · 2026-07-15

该研究基于349例MASLD患者临床变量进行无偏聚类分析,识别出4个亚组,其中1组5年肝脏相关事件累积发生率较高(24.0%;95% CI 14.8%-37.4%),且校正进展期纤维化后风险仍持续存在。该高风险亚组以免疫驱动表型伴免疫球蛋白A(IgA)过度表达为特征,多变量分析显示IgA升高(≥318 mg/dl)是LRE的独立预测因子(HR=3.17,95% CI 1.27-7.91;p=0.01),并在独立VCTE队列(n=287)和外部队列(n=272)中得到验证。

要点

  • 基于临床变量的聚类分析可识别MASLD中IgA富集的高风险亚型。
  • IgA≥318 mg/dl是肝脏相关事件的独立预测因子(HR=3.17)。
  • 该风险独立于进展期纤维化,并在多个队列中验证。

核心结论

  • 数据驱动聚类识别出一种以肠-肝轴IgA介导免疫激活增强为特征的MASLD新亚型,是疾病进展的关键决定因素。

研究设计与样本

  • 对349例MASLD患者基于临床变量进行无偏聚类分析,随后应用空间转录组学、单细胞RNA测序和免疫组化等多组学分析表征高风险亚组生物学特征。
  • 在独立VCTE队列(n=287)和外部队列(n=272)中进行验证。

主要发现

  • 4个MASLD亚组中,1组5年LRE累积发生率为24.0%(95% CI 14.8%-37.4%),校正进展期纤维化后超额风险持续存在。
  • 该高风险亚组以免疫驱动疾病表型伴IgA过度表达为特征。
  • 多变量分析显示IgA升高(≥318 mg/dl)是LRE的独立预测因子(HR=3.17,95% CI 1.27-7.91;p=0.01)。
  • 空间转录组学和scRNA-seq显示表达IgA的B系细胞在门管区富集,IGHA1高表达区域激活B细胞受体信号、细胞外基质重塑和血管重塑相关通路。
  • 肠道免疫组化和循环EndoCAb IgG水平支持肠道通透性增加与全身及肝内IgA相关免疫激活协同关联。

关键数值与推荐

  • IgA≥318 mg/dl作为LRE独立预测因子的HR=3.17(95% CI 1.27-7.91;p=0.01)。
  • 高风险亚组5年LRE累积发生率为24.0%(95% CI 14.8%-37.4%)。

临床怎么用

  • 基于IgA的分层可改善MASLD高风险患者的风险评估,并支持针对肠-肝轴IgA介导免疫激活的机制性治疗靶向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a complex, multifactorial condition. To achieve truly personalized therapy for MASLD, it will be essential to stratify patients based on clinical and biochemical data by identifying subgroups with distinct disease mechanisms and prognostic trajectories. METHODS: This study conducted unbiased clustering analysis of 349 patients with MASLD based on clinical variables. Multi-omics analyses that included spatial transcriptomics, single-cell RNA sequencing (scRNA-seq), and immunohistochemistry were subsequently applied to characterize the biological features of high-risk subgroups. RESULTS: Among the four identified MASLD subgroups, one cluster showed a higher 5-year cumulative incidence of liver-related events (LREs) (24.0%; 95% CI 14.8%-37.4%), with excess risk persisting after adjustment for advanced fibrosis. This high-risk subgroup was characterized by an immune-driven disease phenotype with excessive immunoglobulin A (IgA) expression. Multivariable analysis identified elevated IgA (≥318 mg/dl) as an independent predictor of LREs (hazard ratio = 3.17, 95% CI 1.27-7.91; p = 0.01), a finding validated in an independent vibration-controlled transient elastography cohort (n = 287) as well as an external multicenter validation cohort (n = 272). Spatial transcriptomics and scRNA-seq analyses demonstrated portal enrichment of IgA-expressing B-lineage cells, with IGHA1-high regions showing activation of pathways related to B-cell receptor signaling, extracellular matrix remodeling, and vascular remodeling. Intestinal immunohistochemistry and circulating EndoCAb IgG levels supported a link between increased gut permeability and coordinated systemic and intrahepatic IgA-associated immune activation. CONCLUSION: A data-driven clustering strategy identified a novel MASLD subtype characterized by enhanced IgA-mediated immune activation along the gut-liver axis as a key determinant of disease progression. This IgA-based stratification improves risk assessment and enables mechanism-based therapeutic targeting in patients with high-risk MASLD. IMPACT AND IMPLICATIONS: This study identified a high-risk MASLD subgroup characterized by elevated IgA levels and increased incidence of liver-related events, independent of fibrosis severity. These findings highlight the relevance of immune dysregulation, particularly IgA-associated responses, in MASLD progression.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Kimura T, Wakabayashi SI, Iwadare T, et al. IgA-enriched phenotype predicts liver-related events in MASLD. J Hepatol. 2026. PMID: 42457042. doi:10.1016/j.jhep.2026.06.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。